There are over 10,000 rare diseases — 95% of which don’t have a cure. It can cost billions of dollars and take more than a decade to develop a new treatment. Because patient populations in the rare disease space can sometimes only consist of a few thousand — or even a few dozen people — drug companies have been hesitant to invest that kind of time and capital developing a drug that’s unlikely to turn a profit.

Drug repurposing flips that model on its head.

Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours.